Boehringer In­gel­heim VC backs plan to send GMO bac­te­ria af­ter tu­mors

Chris Thanos wants to send bac­te­ria af­ter your tu­mors.

Specif­i­cal­ly, he wants to send sal­mo­nel­la af­ter your tu­mors, a ge­net­i­cal­ly mod­i­fied form of the mi­crobe that he and his team have neutered and retro­fit­ted with ge­net­ic war­heads. It’s an at­trac­tive idea, at least to Boehringer In­gel­heim Ven­ture Fund and Panacea Ven­ture, who to­day co-led a $34 mil­lion Se­ries A round for Thanos’s Berke­ley-based com­pa­ny, Ac­tym Ther­a­peu­tics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.